Ma'ruf Amin Gets Vaccinated For COVID-19 at 80 Years Old, Minister Of Health: May This Motivate Other Indonesian Elderly
Vice President Ma'ruf Amin (Photo: Antara)

JAKARTA - Vice President Ma'ruf Amin underwent the COVID-19 vaccination today. Health Minister Budi Gunadi Sadikin also assisted the process of injecting the vaccine for Ma'ruf.

Budi said that Ma'ruf's willingness to get an injection of the COVID-19 vaccine at an advanced age is expected to motivate other elderly people to participate in the national vaccination program.

"The vice president is 80 years old. Hopefully, that can also be an encouragement, motivation, so that Indonesian elderly people who are critical to disease can come and get vaccinated first", Budi said in the Tanah Abang area, Central Jakarta, Wednesday, 17 February.

As is known, Vice President Ma'ruf Amin received an injection of the COVID-19 vaccine made by Sinovac on Wednesday, February 17 morning at around 08.30 a.m. local time at the vice president's office in Jakarta.

"It's true (the vice president was vaccinated) at 08.30 a.m. local time at the official residence", said the spokesman for Vice President Masduki Baidlowi.

As previously reported, the injection of the COVID-19 vaccine for Vice President Ma'ruf awaited a recommendation from the Presidential Team of Doctors considering the Vice President's health condition who had a history of comorbid diseases.

"The vice president is ready (to be vaccinated) at any time, but that will later be determined by the health team and the Presidential Team of Doctors. The Presidential Team of Doctors has moved, in terms of what the possibilities are, whether to follow Sinovac or follow other (vaccines)", Masduki said some time ago.

On February 5, the Food and Drug Control Agency (BPOM) issued a permit for the emergency use of the vaccine made by Sinovac, CoronaVac, for groups of people over 60 years of age in Indonesia.

Vaccination for the elderly is permitted by injection of two doses, each of which is given an interval of 28 days.

The emergency use permit, according to the Head of BPOM Penny Lukito, is based on the results of monitoring of phase I and II clinical trial processes in China, which are given to residents over 60 years old.

The results of the clinical trial in China, of the 400 elderly people who were given the Coronavac vaccine injection had an immune level of up to 97.96 percent after the second injection.

The BPOM also considered the results of the Phase III clinical trial in Brazil, which showed that injections of the vaccine to 609 elderly people generally had mild side effects, namely pain, nausea, fever, swelling, redness of the skin, and headaches.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)